Hearing News Watch

Featured image for “2023 Digital EUHA Spring Conference Now Available On-Demand”
Apr. 07, 2023

2023 Digital EUHA Spring Conference Now Available On-Demand

HHTM
MAINZ, GERMANY — The 2023 Digital EUHA Spring Conference commenced on 31st March 2023. The conference provides the opportunity to access all the lectures online until May 31, 2023. The event features a specialist lecture programme and themed presentations offered by manufacturers. A live chat with Q&A sessions with speakers and manufacturers was conducted during the lunch break, providing an
Featured image for “Beltone Names Michael Andreozzi as Brand Ambassador to Support Growth of Independent Network”
Apr. 07, 2023

Beltone Names Michael Andreozzi as Brand Ambassador to Support Growth of Independent Network

HHTM
GLENVIEW, ILLINOIS — Hearing care retailer, Beltone, has announced the appointment of Michael Andreozzi as Beltone Brand Ambassador. In his new role, Andreozzi will support the growth of the company’s independent network and help hearing care professionals succeed in their practices. Andreozzi has been in hearing aid retail for over 40 years and joined the Beltone network as an independent
Featured image for “Third Annual Future of Hearing Healthcare Conference to Take Place May 17, 24 and 31, 2023”
Mar. 31, 2023

Third Annual Future of Hearing Healthcare Conference to Take Place May 17, 24 and 31, 2023

HHTM
Hearing Health & Technology Matters (HHTM) is pleased to announce the third annual Future of Hearing Healthcare Conference will take place May 17, 24 and 31, 2023. The three-day virtual event will provide attendees with insights into the latest treatment, research and technology innovations that will have a hand in shaping the future of hearing care. “Neural networks, OTC, regenerative
Featured image for “Decibel Therapeutics Receives European Orphan Drug Designation for Lead Gene Therapy Candidate DB-OTO”
Mar. 30, 2023

Decibel Therapeutics Receives European Orphan Drug Designation for Lead Gene Therapy Candidate DB-OTO

HHTM
BOSTON, MASSACHUSSETTS — Decibel Therapeutics (Nasdaq: DBTX), a clinical-stage biotechnology company dedicated to discovering and developing transformative treatments to restore and improve hearing and balance, has announced that the European Medicines Agency (EMA) Committee on Orphan Medicinal Products (COMP) has issued a positive opinion on orphan drug designation for DB-OTO, Decibel’s lead gene therapy product candidate. DB-OTO is being developed
Featured image for “Starkey’s CTO Achin Bhowmik, Ph.D., Gives Keynote Presentation at 2023 tinyML Summit”
Mar. 30, 2023

Starkey’s CTO Achin Bhowmik, Ph.D., Gives Keynote Presentation at 2023 tinyML Summit

HHTM
EDEN PRAIRIE, MINNESOTA – Dr. Achin Bhowmik, Starkey’s Chief Technology Officer and Executive Vice President of Engineering, was the keynote speaker at the 2023 tinyML Summit earlier this week. This premier annual event gathers professionals and decision-makers in the tinyML ecosystem, with this year’s event focused on end-users and applications of tinyML. In his presentation, Dr. Bhowmik discussed the neuroscience of hearing, technologies
Featured image for “Spiral Therapeutics Acquires Otonomy Assets to Enhance Inner Ear Disorder Pipeline and Enlists Industry Leaders to the Board”
Mar. 29, 2023

Spiral Therapeutics Acquires Otonomy Assets to Enhance Inner Ear Disorder Pipeline and Enlists Industry Leaders to the Board

HHTM
SAN DIEGO, CALIFORNIA — Spiral Therapeutics, a clinical-stage company specializing in therapies for inner ear disorders, has successfully completed the acquisition of selected assets from Otonomy. This followed the stockholder approval of Otonomy’s dissolution. The acquisition includes preclinical and clinical data related to OTO-104 (OTIVIDEX), OTO-510, an otoprotectant, and preclinical and clinical data and inventory related to OTO-413, a sustained-exposure
Featured image for “Northwestern Study Reveals Importance of the Protein Prestin for High-Frequency Hearing”
Mar. 29, 2023

Northwestern Study Reveals Importance of the Protein Prestin for High-Frequency Hearing

HHTM
A new study by Northwestern Medicine has found that the fast motor kinetics of the protein prestin, found in the inner ear, are crucial for hearing high-frequency sounds. The study, published in the Proceedings of the National Academy of Sciences, sheds light on how outer hair cells in the ear’s cochlea amplify and help us hear high-frequency sounds. All mammals,
Featured image for “Starkey Chief Philanthropy Officer, Tani Austin, Named a 2023 Women in Business Award Honoree”
Mar. 29, 2023

Starkey Chief Philanthropy Officer, Tani Austin, Named a 2023 Women in Business Award Honoree

HHTM
EDEN PRAIRIE, MINNESOTA – Starkey Chief Philanthropy Officer, Tani Austin, has been named a 2023 Women in Business award honoree by the Minneapolis/St. Paul Business Journal. This award honors industry-leading executives, entrepreneurs, and business owners for their professional successes and contributions to the Twin Cities community. “I want to express my sincere congratulations to Tani on this well-deserved recognition,” said Starkey President and CEO Brandon Sawalich. “Tani has a deep-rooted passion
Featured image for “Oticon Government Services Celebrates Homes for Our Troops Donation of Specially Adapted Custom Home for Injured Veteran”
Mar. 27, 2023

Oticon Government Services Celebrates Homes for Our Troops Donation of Specially Adapted Custom Home for Injured Veteran

HHTM
Oticon Government Services joined with Homes For Our Troops (HFOT), government and military officials in a ribbon-cutting ceremony for the newly-built specially adapted custom home for medically retired Marine Corporal Daniel Lasko. Since 2017, Oticon Government Services has been a proud supporter of the national non-profit’s work of building and donating specially adapted custom homes nationwide to severely injured post-9/11
Featured image for “Eargo Reports Q4 2022 Financial Results”
Mar. 27, 2023

Eargo Reports Q4 2022 Financial Results

HHTM
SAN JOSE, CALIFORNIA — Eargo, Inc. (Nasdaq: EAR) has released its financial results for the fourth quarter of 2022, ending on December 31st, 2022. Eargo reported net revenues of $12.9 million, compared to $10.1 million for the same period in 2021 and $7.9 million in the third quarter of 2022. Gross systems shipped in the fourth quarter were 8,863, up